U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07114536) titled 'Evaluation of the Efficacy of Calcium a -Ketoglutarate(AKG-Ca) in Lmproving Human Aging' on July 31.
Brief Summary: This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the effects of calcium alpha-ketoglutarate (CaAKG) supplementation on biological aging and age-related health indicators in middle-aged and older adults. Alpha-ketoglutarate (AKG), a key intermediate in the Krebs cycle, has been investigated for its potential role in modulating aging-related metabolic and cellular pathways. Due to the poor oral bioavailability of free AKG, its stabilized form-calcium alpha-ketoglutarate (CaAKG)-is used to...